Global /South Korea /Technology /Software - Application /328130

Lunit Inc.

328130

• KRX: 328130 • Delayed

41,450KRW 0.6%

26.57 USD

As of 6 June 2026, Lunit Inc. has a market cap of $791.9M USD, ranking #12117 globally and #332 in South Korea. It ranks #1815 in the Technology sector, and #523 in the Software - Application industry.

Global Rank

12117

Country Rank

332

Sector Rank

1815

Industry Rank

523

Key Stats

Market Cap

$791.9MUSD

1.21T KRW

Enterprise Value

$836.28MUSD

1.3T KRW

Revenue (TTM)

$54.23MUSD

83.13B KRW

EBITDA (TTM)

-$46.67MUSD

-72.8B KRW

Net Income (TTM)

-$30.92MUSD

-47.39B KRW

EBITDA Margin

-88%

Profit Margin

-57%

PS Ratio

14.6

PB Ratio

8.8

Company Profile

Country (HQ)

South Korea

Sector

Technology

Industry

Software - Application

CEO

Beomseok Brandon Suh open_in_new

Founded

2013

Website

lunit.io open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.6%	15%	19%	-12%	1%	0.2%	-23%	56%	118%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	328130 루닛 ISIN: KR7328130000 Shares Out.: Shares Outstanding: 74.383M¹ Shares Float: 53.371M² TV: TradingView: KRX: 328130 SA: Stock Analysis: KRX: 328130 YF: Yahoo Finance: 328130.KS GF: Google Finance: KRX: 328130 BA: Barron's: 328130 MS: Morningstar: XKRX: 328130	41,450 KRW	TV: TradingView: KRX: 328130 SA: Stock Analysis: KRX: 328130 YF: Yahoo Finance: 328130.KS GF: Google Finance: KRX: 328130 BA: Barron's: 328130 MS: Morningstar: XKRX: 328130

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Lunit Inc.

Lunit Inc. provides AI-powered software and solutions for cancer diagnostics and therapeutics in South Korea. It offers AI solution for chest X-ray and mammography, as well as AI solution for digital breast tomosynthesis, and AI-powered biomarker for immune phenotyping and PD-L1 biomarker analyzer. The company has a strategic collaboration with AstraZeneca for the development of Lunit SCOPE Genotype Predictor, an AI-powered tool capable of analyzing H&E slide images to predict the likelihood of the tumor harboring NSCLC driver mutations, such as Epidermal Growth Factor Receptor mutations; with Agilent Technologies Inc. to create advanced solutions that meet the demand of novel and complex biomarker assays in drug development; and with Daiichi Sankyo Company, Limited to accelerate biomarker discovery and translational research. Lunit Inc. was founded in 2013 and is based in Seoul, South Korea.

Similar Companies

Industry: Software - Application (South Korea)

Name	Market Cap (USD) diff.	PE	Country
NAVER Corp. KRX: 035420	$21.47B 32.91T KRW 3K%	17.0	South Korea
KRAFTON, Inc. KRX: 259960	$8.08B 12.39T KRW 921%	17.0	South Korea
NC Corp. KRX: 036570	$3.51B 5.38T KRW 343%	15.5	South Korea
Netmarble Corp. KRX: 251270	$2.52B 3.87T KRW 219%	18.6	South Korea
Pearl Abyss Corp. KRX: 263750	$2.4B 3.68T KRW 203%	-	South Korea
Douzone Bizon Co., Ltd. KRX: 012510	$2.2B 3.36T KRW 177%	38.7	South Korea

Industry: Software - Application (Global)

Name	Market Cap (USD) diff.	PE	Country
Alphabet Inc. NASDAQ: GOOG	$4.23T 533K%	32.0	United States
Microsoft Corp. NASDAQ: MSFT	$3.15T 398K%	26.6	United States
Meta Platforms, Inc. NASDAQ: META	$1.7T 215K%	28.5	United States
Tencent Holdings Ltd. SHEK: 700	$551.68B 4.32T HKD 70K%	17.8	China
Oracle Corp. NYSE: ORCL	$471.18B 59K%	29.4	United States
Netflix, Inc. NASDAQ: NFLX	$387.9B 49K%	29.8	United States

chevron_leftBack